New combo may speed stem cell harvest for myeloma patients

NCT ID NCT05087212

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a combination of two drugs, plerixafor and G-CSF, to help collect stem cells from the blood of 53 people with multiple myeloma. The goal was to see if this approach could gather enough healthy stem cells for a transplant in fewer sessions. Results showed the combination was effective and safe for most participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: plerixafor and G-CSF (drug combination)
What this could lead to: If successful, this combination could make stem cell collection faster and more reliable for multiple myeloma patients needing a transplant.
What could go wrong: This is a small, single-group study (53 people) with no comparison group, so results may not apply to all patients. The treatment is for stem cell collection, not a cure for myeloma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT

Contacts and locations

Locations

Investigational Sites

China, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.